Effect of salmon calcitonin on femoral bone quality in adult ovariectomized ewes

Calcified Tissue International

Volumn 59, Issue 4, 1996, Pages 315-320

  Geusens, P ^a,b   Boonen, S ^b   Nijs, J ^b   Jiang, Y ^b   Lowet, G ^b   Van Auderkercke, R ^b   Huyghe, C ^c   Caulin, F ^c   Very, J M ^d   Dequeker, J ^b   Van Der Perre, G ^b  

^a HASSELT UNIVERSITY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c Arthr and Metab Bone Dis Res U ^*  (Belgium)

^d Biomedical Research Department   (United Kingdom)

Author keywords

Bone quality; Calcitonin; Crystallography; Ewe; Ovariectomy

Indexed keywords

SALCATONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE MINERAL; CONTROLLED STUDY; FEMALE; FEMUR; HORMONAL REGULATION; HORMONE ACTION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; SHEEP; X RAY DIFFRACTION;

ANIMALS; BONE DENSITY; CALCITONIN; CRYSTALLOGRAPHY, X-RAY; FEMALE; FEMUR; OVARIECTOMY; SALMON; SHEEP;

EID: 10244262736     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002239900132     Document Type: Article

References (24)

1. Overgaard K, Hansen MA, Jensen B, Christiansen C (1992) Effect of calcitonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study. BMJ 305:556-561
2. Farley JR, Tarbaux NM, Hall SL, et al (1988) The anti-bone resorptive agent calcitonin also acts in vitro to directly increase bone formation and bone cell proliferation. Endocrinology 123:159-167
3. 3[H]-Thymidine incorporation and alkaline phosphatase activity in human osteoblast-line cells. Calcif Tissue Int 48:297-301
4. Civitelli R, Gonnelli S, Zachei F, Bigazzi S, Vattimo A, Avioli LV, Gennari C (1988) Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. J Clin Invest 82: 1268-1274
5. Kanis JA, Johnell O, Gullberg B, et al (1992) Evidence for the efficacy of bone active drugs in the prevention of hip fracture. BMJ 305:1124-1128
6. Overgaard KY (1994) Effect of intranasal calcitonin therapy on bone mass and bone turnover in early postmenopausal women: a dose response study. Calcif Tissue Int 55:82-86
7. Food and Drug Administration, Division of Metabolism and Endocrine Drug Products (1992) Guidelines for preclinical and clinical evaluation of agents used in the prevention or treatment of postmenopausal osteoporosis.
8. Hayashi T, Yamamuro T, Okumura H, et al (1989) Effect of (Asu1,7)-eel calcitonin on the prevention of osteoporosis induced by combination of immobilization and ovariectomy in the rat. Bone 10:25-28
9. Wronski TJ, Yen CF, Burton KW, et al (1991) Skeletal effects of calcitonin in ovarectomized rats. Endocrinology 129:2246-2250
10. Ekeland A, Myhre L, Underdale T (1983) Effects of salmon calcitonin on mechanical properties of healing and intact bone and skin in rats. Acta Orthop Scand 54:462-469
11. Goldstein SA, Goulet R, McCubbrey D (1993) Measurement and significance of three-dimensional architecture to mechanical integrity of trabecular bone. Calcif Tissue Int 53(suppl 1):S127-S133
12. Martens M, Van Audekercke R, De Meester P, Mulier JC (1980) The mechanical characteristics of the long bones of the lower extremity in torsional loading. J Biomechanics 13:667-676
13. Cornelissen P, Cornelissen M, Van der Perre G (1986) Assessment of tibial stiffness by vibration testing in situ - II. Influence of soft tissues, joints and fibula. J Biomechanics 19:551-561
14. Mosekilde L, Mosekilde L (1986) Normal vertebral body size and compressive strength: relations to age and to vertebral and iliac trabecular bone compressive strength. Bone 7:207-212
15. Very JM, Baud CA (1984) X-ray diffraction of calcified tissues. In: Dickson GR (ed) Methods of calcified tissue preparation. Elsevier, Amsterdam, pp 369-387
16. Baud CA, Very JM (1982) Morphological and crystaliographic analysis of bone mineral. In: Anghileri LJ, Tuffet-Anghileri A (eds) The role of calcium in biological systems. Boca Raton, CRC Press, pp 95-102
17. Newman E, Turner AS, Wark JD (1995) The potential of sheep for the study of osteopenia: current status and comparison with other animal models. Bone 4 (suppl):277S-284S
18. Carter DR, Hayes WC (1977) The compressive behavior of bone as a two-phase porous structure. J Bone Joint Surg 59-A:954-962
19. Smith CB, Smith DA (1976) Relations between age, mineral density and mechanical properties of human femoral compacta. Acta Orth Scand 47:496-502
20. Machin D, Campbell MJ (1987) Statistical tables for the design of clinical trials. Blackwell Scientific Publications, Oxford, UK
21. Chesnut CH (1995) Drug therapy; calcitonin, bisphosphonates, and anabolic steroids. In: Riggs BL, Melton LJ (eds) Osteoporosis: etiology, diagnosis and management. Lippincott-Raven Publishers, Philadelphia, USA
22. Grynpass MD, Acito A, Dimitriu M, et al (1992) Changes in bone mineralization, architecture and mechanical properties due to long-term (1 year) administration of pamidronate (APD) to adult dogs. Osteoporosis Int 2:74-81
23. Palmieri GMA, Pitcock JA. Brown P, et al (1989) Effect of calcitonin and vitamin D in osteoporosis. Calcif Tissue Int 45:137-141
24. Kröger H, Arnala I, Alhava EM (1992) Effect of calcitonin on bone histomorphometry and bone metabolism in rheumatoid arthritis. Calcif Tissue Int 50:11-13